Ibrutinib combined with bendamustine and rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): First results from a randomized, double-blind, placebo-controlled, phase III study


Chanan-Khan A. A. A., Cramer P., DEMİRKAN F., Fraser G., Silva R. S., Pylypenko H., ...More

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 33
  • Doi Number: 10.1200/jco.2015.33.18_suppl.lba7005
  • City: Illinois
  • Country: United States Of America
  • Dokuz Eylül University Affiliated: Yes